John D Buynak

7PUBLICATIONS
12CO-AUTHORS
Special needs dentistryMedical bacteriologyMolecular targetsMedical infection agents (incl. prions)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 18, 2026
The Novel Carbapenem, JDB/PQ-1-219, Has Potent Broad Spectrum Activity against Multi-Drug Resistant Acinetobacter baumannii.

|Aug 20, 2025
Dual mechanism of the OXA-23 carbapenemase inhibition by the carbapenem NA-1-157.

Marta Toth, Nichole K Stewart, Pojun Quan

|Jun 17, 2025
Novel C5α-substituted carbapenems enhance Mycobacterium abscessus killing via selective target binding and reduced hydrolysis by BlaMab.

Eunjeong Shin, Magdalena A Taracila, Pojun Quan

|Nov 27, 2024
Decarboxylation of the Catalytic Lysine Residue by the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the OXA-58 Carbapenemase.

Marta Toth, Nichole K Stewart, Ailiena O Maggiolo

|Mar 21, 2024
Restricted Rotational Flexibility of the C5α-Methyl-Substituted Carbapenem NA-1-157 Leads to Potent Inhibition of the GES-5 Carbapenemase.

Nichole K Stewart, Marta Toth, Pojun Quan

|May 02, 2023
The C5α-Methyl-Substituted Carbapenem NA-1-157 Exhibits Potent Activity against Klebsiella spp. Isolates Producing OXA-48-Type Carbapenemases.

Clyde A Smith, Nichole K Stewart, Marta Toth

Pageof 2

Frequent Collaborators

5 joint publications

Clyde A Smith

5 joint publications

Sergei B Vakulenko

1 joint publications

Leighanne A Brammer Basta

1 joint publications

Kyle H Rohde